Literature DB >> 21310526

MicroRNA-542-5p as a novel tumor suppressor in neuroblastoma.

Isabella Bray1, Amanda Tivnan, Kenneth Bryan, Niamh H Foley, Karen M Watters, Lorraine Tracey, Andrew M Davidoff, Raymond L Stallings.   

Abstract

Several studies have implicated the dysregulation of microRNAs in neuroblastoma pathogenesis, an often fatal paediatric cancer arising from precursor cells of the sympathetic nervous system. Our group and others have demonstrated that lower expression of miR-542-5p is highly associated with poor patient survival, indicating a potential tumor suppressive function. Here, we demonstrate that ectopic over-expression of this miRNA decreases the invasive potential of neuroblastoma cell lines in vitro, along with primary tumor growth and metastases in an orthotopic mouse xenograft model, providing the first functional evidence for the involvement of miR-542-5p as a tumor suppressor in any type of cancer.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21310526      PMCID: PMC3057396          DOI: 10.1016/j.canlet.2011.01.016

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  25 in total

1.  A comparison of normalization methods for high density oligonucleotide array data based on variance and bias.

Authors:  B M Bolstad; R A Irizarry; M Astrand; T P Speed
Journal:  Bioinformatics       Date:  2003-01-22       Impact factor: 6.937

2.  Exploration, normalization, and summaries of high density oligonucleotide array probe level data.

Authors:  Rafael A Irizarry; Bridget Hobbs; Francois Collin; Yasmin D Beazer-Barclay; Kristen J Antonellis; Uwe Scherf; Terence P Speed
Journal:  Biostatistics       Date:  2003-04       Impact factor: 5.899

Review 3.  MicroRNAs: small RNAs with a big role in gene regulation.

Authors:  Lin He; Gregory J Hannon
Journal:  Nat Rev Genet       Date:  2004-07       Impact factor: 53.242

4.  Accurate prediction of neuroblastoma outcome based on miRNA expression profiles.

Authors:  Johannes H Schulte; Benjamin Schowe; Pieter Mestdagh; Lars Kaderali; Prabhav Kalaghatgi; Stefanie Schlierf; Joelle Vermeulen; Bent Brockmeyer; Kristian Pajtler; Theresa Thor; Katleen de Preter; Frank Speleman; Katharina Morik; Angelika Eggert; Jo Vandesompele; Alexander Schramm
Journal:  Int J Cancer       Date:  2010-11-15       Impact factor: 7.396

5.  Chromosome 1p and 11q deletions and outcome in neuroblastoma.

Authors:  Edward F Attiyeh; Wendy B London; Yael P Mossé; Qun Wang; Cynthia Winter; Deepa Khazi; Patrick W McGrady; Robert C Seeger; A Thomas Look; Hiroyuki Shimada; Garrett M Brodeur; Susan L Cohn; Katherine K Matthay; John M Maris
Journal:  N Engl J Med       Date:  2005-11-24       Impact factor: 91.245

Review 6.  Therapeutic targeting of miRNAs in neuroblastoma.

Authors:  Raymond L Stallings; Niamh H Foley; Kenneth Bryan; Patrick G Buckley; Isabella Bray
Journal:  Expert Opin Ther Targets       Date:  2010-09       Impact factor: 6.902

7.  Proliferation and invasion: plasticity in tumor cells.

Authors:  Chong-Feng Gao; Qian Xie; Yan-Li Su; Julie Koeman; Sok Kean Khoo; Margaret Gustafson; Beatrice S Knudsen; Rick Hay; Nariyoshi Shinomiya; George F Vande Woude
Journal:  Proc Natl Acad Sci U S A       Date:  2005-07-15       Impact factor: 11.205

8.  A developmental model of neuroblastoma: differentiating stroma-poor tumors' progress along an extra-adrenal chromaffin lineage.

Authors:  J C Hoehner; C Gestblom; F Hedborg; B Sandstedt; L Olsen; S Påhlman
Journal:  Lab Invest       Date:  1996-11       Impact factor: 5.662

9.  Are gains of chromosomal regions 7q and 11p important abnormalities in neuroblastoma?

Authors:  R L Stallings; J Howard; A Dunlop; M Mullarkey; M McDermott; F Breatnach; A O'Meara
Journal:  Cancer Genet Cytogenet       Date:  2003-01-15

10.  Differential patterns of microRNA expression in neuroblastoma are correlated with prognosis, differentiation, and apoptosis.

Authors:  Yongxin Chen; Raymond L Stallings
Journal:  Cancer Res       Date:  2007-02-01       Impact factor: 12.701

View more
  39 in total

1.  Extensive miRNA expression analysis in craniopharyngiomas.

Authors:  Jill Samis; Elio F Vanin; Simone Treiger Sredni; Maria de Fátima de Bonaldo; Fabricio F Costa; Tadanori Tomita; Reema Habiby; Donald Zimmerman; Marcelo B Soares
Journal:  Childs Nerv Syst       Date:  2016-06-07       Impact factor: 1.475

Review 2.  The role of genetic and epigenetic alterations in neuroblastoma disease pathogenesis.

Authors:  Raquel Domingo-Fernandez; Karen Watters; Olga Piskareva; Raymond L Stallings; Isabella Bray
Journal:  Pediatr Surg Int       Date:  2012-12-29       Impact factor: 1.827

3.  MiRNA-335 suppresses neuroblastoma cell invasiveness by direct targeting of multiple genes from the non-canonical TGF-β signalling pathway.

Authors:  Jennifer Lynch; Joanna Fay; Maria Meehan; Kenneth Bryan; Karen M Watters; Derek M Murphy; Raymond L Stallings
Journal:  Carcinogenesis       Date:  2012-03-01       Impact factor: 4.944

Review 4.  Current progress for the use of miRNAs in glioblastoma treatment.

Authors:  Amanda Tivnan; Kerrie Leanne McDonald
Journal:  Mol Neurobiol       Date:  2013-04-28       Impact factor: 5.590

5.  Selected miRNA levels are associated with IKZF1 microdeletions in pediatric acute lymphoblastic leukemia.

Authors:  J Krzanowski; J Madzio; A Pastorczak; A Tracz; M Braun; J Tabarkiewicz; A Pluta; W Młynarski; I Zawlik
Journal:  Oncol Lett       Date:  2017-07-18       Impact factor: 2.967

Review 6.  MicroRNA and DNA methylation alterations mediating retinoic acid induced neuroblastoma cell differentiation.

Authors:  Raymond L Stallings; Niamh H Foley; Isabella M Bray; Sudipto Das; Patrick G Buckley
Journal:  Semin Cancer Biol       Date:  2011-07-13       Impact factor: 15.707

7.  Comprehensive MicroRNA expression profiling identifies novel markers in follicular variant of papillary thyroid carcinoma.

Authors:  Matthias Dettmer; Aurel Perren; Holger Moch; Paul Komminoth; Yuri E Nikiforov; Marina N Nikiforova
Journal:  Thyroid       Date:  2013-09-19       Impact factor: 6.568

Review 8.  The roles of microRNAs in neuroblastoma.

Authors:  Hong Mei; Zhen-Yu Lin; Qiang-Song Tong
Journal:  World J Pediatr       Date:  2014-01-25       Impact factor: 2.764

9.  Trichostatin A induces a unique set of microRNAs including miR-129-5p that blocks cyclin-dependent kinase 6 expression and proliferation in H9c2 cardiac myocytes.

Authors:  Gipsy Majumdar; Rajendra Raghow
Journal:  Mol Cell Biochem       Date:  2016-03-05       Impact factor: 3.396

Review 10.  MicroRNAs in neuroblastoma: small-sized players with a large impact.

Authors:  Feng Zhi; Rong Wang; Qiang Wang; Lian Xue; Danni Deng; Suinuan Wang; Yilin Yang
Journal:  Neurochem Res       Date:  2014-01-30       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.